AGEN
Agenus (AGEN)
$94
About Agenus (AGEN)
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Details
Daily high
$3.01
Daily low
$2.78
Price at open
$2.78
52 Week High
$7.34
52 Week Low
$1.38
Market cap
94.2M
Dividend yield
0.00%
Volume
490,206
Avg. volume
908,882
P/E ratio
-1.30
Agenus News
Details
Daily high
$3.01
Daily low
$2.78
Price at open
$2.78
52 Week High
$7.34
52 Week Low
$1.38
Market cap
94.2M
Dividend yield
0.00%
Volume
490,206
Avg. volume
908,882
P/E ratio
-1.30